首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Design, synthesis and 3D-QSAR studies of new diphenylamine containing 1,2,4-triazoles as potential antitubercular agents
【24h】

Design, synthesis and 3D-QSAR studies of new diphenylamine containing 1,2,4-triazoles as potential antitubercular agents

机译:含有1,2,4-三唑作为潜在抗细胞剂的新二苯胺的设计,合成和3D-QSAR研究

获取原文
获取原文并翻译 | 示例
           

摘要

A new series of new diphenylamine containing 1,2,4-triazoles were synthesized from 4-arylideneamino-5-[2-(2,6-dichlorophenylamino) benzyl]-2H-1,2,4-triazole-3(4H)-thiones 3a-f. The synthesized compounds were screened for in-vitro antimycobacterial and antibacterial activities. The synthesized compounds 4a, 4e and 4d have shown potential activity against Mycobacterium tuberculosis H(37)Rv strain with MIC of 0.2, 1.6 and 3.125 mu M respectively. To investigate the SAR of diphenylamine containing 1,2,4-triazole derivatives in more details, CoMFA (q(2)-0.432, r(2)-0.902) and CoMSIA (q(2)-0.511, r(2)-0.953) models on M. tuberculosis H(37)Rv were established. The generated 3D-QSAR models are externally validated and have shown significant statistical results, and these models can be used for further rational design of novel diphenylamine containing 1,2,4-triazoles as potent antitubercular agents. (C) 2014 Elsevier Masson SAS. All rights reserved.
机译:从4-亚芳基氨基-5- [2-(2,6-二氯苯基氨基)苄基] -2H-1,2,4-三唑-3(4H)中合成了一种新的新的二苯胺系列含有1,2,4-三唑的新二苯胺。-2H-1,2,4-三唑-3(4H) - 第3A-F。 将合成的化合物筛选用于体外抗微生物和抗菌活性。 合成的化合物4a,4e和4d示出了分枝杆菌H(37)rV菌株的潜在活性,分别为0.2,1.6和3.125μm的MIC。 为了了解含有1,2,4-三唑衍生物的二苯胺的SAR更详细的细节,COMFA(Q(2)-0.432,R(2)-0.902)和COMSIA(Q(2)-0.511,R(2) - 0.953)在M.Tuberculosis H(37)RV上的模型。 外部验证所产生的3D-QSAR模型并显示出显着的统计结果,这些模型可用于进一步理性设计,用于含有1,2,4-三唑的新型二苯胺设计为有效的抗细胞剂。 (c)2014年Elsevier Masson SAS。 版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号